Curetis
Latest round
- Series B
Last raised
- Jun 2014
Total raised
- $74M
Investors
- 11
About Curetis
Curetis AG specializes in rapid molecular diagnostics, focusing on the detection of infectious diseases and antimicrobial resistance.Curetis AG is a molecular diagnostics company founded in 2007 and headquartered in Holzgerlingen, Germany. The firm focuses on developing and commercializing innovative diagnostic solutions. The company's CEO, Albert Weber, leads its operations.Curetis GmbH's core product, the Unyvero A50 Solution, is a rapid molecular diagnostic system designed to detect a wide range of pathogens and antimicrobial resistance markers. It delivers results in less than five hours with only two minutes of hands-on time, enabling healthcare professionals to make swift, informed treatment decisions in managing severe infections.70 for 2020, with an EBITDA of EUR -8,733,612.Curetis AG aims to expand its product offerings by launching new applications for its Unyvero A50 system, targeting an increase in diagnostic capabilities over the next few years. The company also plans to penetrate new geographical markets, focusing on regions in Asia and North America by 2025.
Who invested in Curetis
11 investors across 5 rounds
See all investors in Curetis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Curetis
Who invested in Curetis?
Curetis has 11 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Curetis raised?
Curetis has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Curetis last raise money?
Curetis's most recent round on record is a Series B, in Jun 2014.
What does Curetis do?
Curetis AG specializes in rapid molecular diagnostics, focusing on the detection of infectious diseases and antimicrobial resistance.
Where is Curetis headquartered?
Curetis is headquartered in Holzgerlingen, Germany.
Which VCs invest in companies like Curetis?
Among active investors with capital left to deploy, Index Ventures, Forbion, Balderton Capital and Sofinnova Partners back healthcare companies at Curetis's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like Curetis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.